Characterization of oral candidiasis and the Candida species profile in patients with oral mucosal diseases.


Journal

Microbial pathogenesis
ISSN: 1096-1208
Titre abrégé: Microb Pathog
Pays: England
ID NLM: 8606191

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 15 02 2019
revised: 28 05 2019
accepted: 04 06 2019
pubmed: 9 6 2019
medline: 7 1 2020
entrez: 9 6 2019
Statut: ppublish

Résumé

The oral mucosa is likely to be compromised by acquired systemic disease. There are no data available on the prevalence of oral candidiasis and the species distribution among patients with oral mucosal diseases. Therefore, it is necessary to conduct a study assessing the characterization of oral candidiasis and the species profiles in such patients. Over a period of four consecutive years, patients with oral mucosal diseases were screened for oral candidiasis by a combination of clinical presentation and laboratory findings (smear test and Candida cultures). In addition, Candida species were isolated and identified for further analysis. In total, 9769 (6.09%) of the 160,357 patients screened were diagnosed with oral candidiasis on the basis of both clinical manifestations and laboratory testing. The ratio of females to males was 1:0.61, and females had higher overall infection rates than males in all age subgroups. Patients with HIV infection, anaemia-related stomatitis, Sjögren's syndrome/xerostomia, pemphigoid, and radiation-induced stomatitis were highly susceptible to oral candidiasis. Of the 11,161 isolated Candida strains, C. albicans remained the most common species (75.37%), followed by C. tropicalis (6.06%), C. krusei (2.79%), and C. glabrata (2.02%). Surprisingly, both the proportion and the number of C. glabrata isolates increased dramatically over the 4 consecutive years. In this large-scale population-based study, the features of oral candidiasis prevalence and the species profile among patients with oral mucosal diseases were summarized. The information gleaned will enhance the understanding of and improve management strategies for oral candidiasis and the underlying systemic and oral conditions.

Sections du résumé

BACKGROUND BACKGROUND
The oral mucosa is likely to be compromised by acquired systemic disease. There are no data available on the prevalence of oral candidiasis and the species distribution among patients with oral mucosal diseases. Therefore, it is necessary to conduct a study assessing the characterization of oral candidiasis and the species profiles in such patients.
METHODS METHODS
Over a period of four consecutive years, patients with oral mucosal diseases were screened for oral candidiasis by a combination of clinical presentation and laboratory findings (smear test and Candida cultures). In addition, Candida species were isolated and identified for further analysis.
RESULTS RESULTS
In total, 9769 (6.09%) of the 160,357 patients screened were diagnosed with oral candidiasis on the basis of both clinical manifestations and laboratory testing. The ratio of females to males was 1:0.61, and females had higher overall infection rates than males in all age subgroups. Patients with HIV infection, anaemia-related stomatitis, Sjögren's syndrome/xerostomia, pemphigoid, and radiation-induced stomatitis were highly susceptible to oral candidiasis. Of the 11,161 isolated Candida strains, C. albicans remained the most common species (75.37%), followed by C. tropicalis (6.06%), C. krusei (2.79%), and C. glabrata (2.02%). Surprisingly, both the proportion and the number of C. glabrata isolates increased dramatically over the 4 consecutive years.
CONCLUSIONS CONCLUSIONS
In this large-scale population-based study, the features of oral candidiasis prevalence and the species profile among patients with oral mucosal diseases were summarized. The information gleaned will enhance the understanding of and improve management strategies for oral candidiasis and the underlying systemic and oral conditions.

Identifiants

pubmed: 31175972
pii: S0882-4010(19)30297-9
doi: 10.1016/j.micpath.2019.103575
pii:
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103575

Informations de copyright

Copyright © 2019. Published by Elsevier Ltd.

Auteurs

Lijun Hu (L)

Department of Oral Medicine, Peking University School and Hospital of Stomatology, 22 South Zhongguancun Ave, Beijing, 100081, China.

Chun He (C)

Department of Clinical Laboratory, Peking University School and Hospital of Stomatology, 22 South Zhongguancun Ave, Beijing, 100081, China.

Chen Zhao (C)

Department of Oral Medicine, Peking University School and Hospital of Stomatology, 22 South Zhongguancun Ave, Beijing, 100081, China.

Xuejie Chen (X)

Department of Oral Medicine, Peking University School and Hospital of Stomatology, 22 South Zhongguancun Ave, Beijing, 100081, China.

Hong Hua (H)

Department of Oral Medicine, Peking University School and Hospital of Stomatology, 22 South Zhongguancun Ave, Beijing, 100081, China.

Zhimin Yan (Z)

Department of Oral Medicine, Peking University School and Hospital of Stomatology, 22 South Zhongguancun Ave, Beijing, 100081, China. Electronic address: yzhimin96@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH